A Study of ONO-1110 in Patients With Postherpetic Neuralgia

A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients With Postherpetic Neuralgia

To evaluate the efficacy and safety of ONO-1110 in Japanese patients with postherpetic neuralgia

Inclusion Criteria:

• Japanese (both sexes)
• Age (at the time of informed consent): 18 years and older
• Outpatient
• Patients with persistent pain ≥3 months (90 days) after the onset of herpes zoster
• Patients who are considered capable of understanding the study procedures and completing the pain diary and questionnaires appropriately by the investigator (sub-investigator)

Exclusion Criteria:

• Patients who previously underwent neurodestruction or neurosurgical therapy for PHN
• Patients with pain other than PHN that may affect assessments in this study
• Patients with any skin condition related to the site of herpes zoster that may affect assessments in this study
• Patients with a past history of or concurrent neurologic diseases that may affect assessments in this study
• Patients with concurrent psychiatric diseases that may affect assessments in this study